Evidence map›Paper›PMID 38793013›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Diabetic Nephropathy, Retinopathy, and Functional Hypogonadism in a Patient with MODY10: A Case Report.

Rossana Ruiz-Urbaez, Mariela Viviana Villagómez-Estrada, Carlos Reyes-Silva, Darlyng Quishpe-López, David Males-Maldonado, Jorge Salazar-Vega, Enrique Gea-Izquierdo

Abstract readCase Reports
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rossana Ruiz-UrbaezUnit of Endocrinology and Diabetes, Eugenio Espejo Hospital, Quito 170403, Ecuador.
Mariela Viviana Villagómez-EstradaUnit of Endocrinology, Dr. José Eleuterio González Hospital, Monterrey 64460, Mexico.ORCID 0000-0001-6838-1469
Carlos Reyes-SilvaUnit of Genetic, Eugenio Espejo Hospital, Quito 170403, Ecuador.ORCID 0000-0002-1141-3279
Darlyng Quishpe-LópezUnit of Endocrinology and Diabetes, Eugenio Espejo Hospital, Quito 170403, Ecuador.
David Males-MaldonadoUnit of Endocrinology and Diabetes, Eugenio Espejo Hospital, Quito 170403, Ecuador.
Jorge Salazar-VegaUnit of Endocrinology and Diabetes, Eugenio Espejo Hospital, Quito 170403, Ecuador.
Enrique Gea-IzquierdoFaculty of Medicine, Pontifical Catholic University of Ecuador, Quito 170143, Ecuador.ORCID 0000-0002-7123-6251

Funding

María Zambrano Program, European Union-Spain Not applicable
6 · The paper itself

Abstract

(1)

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesDiabetic RetinopathyHypogonadismAdolescentHumansMalehypogonadismINS genematurity-onset diabetes of the young (MODY)nephropathyretinopathy

Identifiers

PMID38793013
PMCPMC11123248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.